Nikko Asset Management Americas, Inc. Ionis Pharmaceuticals Inc Transaction History
Nikko Asset Management Americas, Inc.
- $8.57 Billion
- Q2 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 199,231 shares of IONS stock, worth $7.91 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
199,231
Previous 220,261
9.55%
Holding current value
$7.91 Million
Previous $9.55 Million
0.56%
% of portfolio
0.11%
Previous 0.1%
Shares
22 transactions
Others Institutions Holding IONS
# of Institutions
389Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$502 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$410 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$328 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$261 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.64B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...